BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27814991)

  • 21. CHCHD2 harboring Parkinson's disease-linked T61I mutation precipitates inside mitochondria and induces precipitation of wild-type CHCHD2.
    Cornelissen T; Spinazzi M; Martin S; Imberechts D; Vangheluwe P; Bird M; De Strooper B; Vandenberghe W
    Hum Mol Genet; 2020 May; 29(7):1096-1106. PubMed ID: 32068847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction.
    Zhou W; Ma D; Sun AX; Tran HD; Ma DL; Singh BK; Zhou J; Zhang J; Wang D; Zhao Y; Yen PM; Goh E; Tan EK
    Hum Mol Genet; 2019 Apr; 28(7):1100-1116. PubMed ID: 30496485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CHCHD2 p.Thr61Ile knock-in mice exhibit motor defects and neuropathological features of Parkinson's disease.
    Fan L; Zhang S; Li X; Hu Z; Yang J; Zhang S; Zheng H; Su Y; Luo H; Liu X; Fan Y; Sun H; Zhang Z; Miao J; Song B; Xia Z; Shi C; Mao C; Xu Y
    Brain Pathol; 2023 May; 33(3):e13124. PubMed ID: 36322611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TMEM230 Mutations Are Rare in Han Chinese Patients with Autosomal Dominant Parkinson's Disease.
    Wei Q; Ou R; Zhou Q; Chen Y; Cao B; Gu X; Zhao B; Wu Y; Song W; Shang HF
    Mol Neurobiol; 2018 Apr; 55(4):2851-2855. PubMed ID: 28455698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New Genes Causing Hereditary Parkinson's Disease or Parkinsonism.
    Puschmann A
    Curr Neurol Neurosci Rep; 2017 Sep; 17(9):66. PubMed ID: 28733970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of CHCHD2 mutations in patients with Alzheimer's disease, amyotrophic lateral sclerosis and frontotemporal dementia in China.
    Liu X; Jiao B; Zhang W; Xiao T; Hou L; Pan C; Tang B; Shen L
    Mol Med Rep; 2018 Jul; 18(1):461-466. PubMed ID: 29749507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic screening of Filipinos suspected with familial Parkinson's disease: A pilot study.
    Caritativo ECA; Yu JRT; Bautista JMP; Nishioka K; Jamora RDG; Yalung PM; Ng AR; Hattori N
    Parkinsonism Relat Disord; 2023 Mar; 108():105319. PubMed ID: 36774704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation analysis of CHCHD2 and CHCHD10 in Italian patients with mitochondrial myopathy.
    Rubino E; Zhang M; Mongini T; Boschi S; Vercelli L; Vacca A; Govone F; Gai A; Giordana MT; Grinberg M; Rogaeva E; Rainero I
    Neurobiol Aging; 2018 Jun; 66():181.e1-181.e2. PubMed ID: 29519717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematically analyzing rare variants of autosomal-dominant genes for sporadic Parkinson's disease in a Chinese cohort.
    Yang N; Zhao Y; Liu Z; Zhang R; He Y; Zhou Y; Xu Q; Sun Q; Yan X; Guo J; Tang B
    Neurobiol Aging; 2019 Apr; 76():215.e1-215.e7. PubMed ID: 30598256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TMEM230 mutation analysis in Parkinson's disease in a Chinese population.
    Yan W; Tang B; Zhou X; Lei L; Li K; Sun Q; Xu Q; Yan X; Guo J; Liu Z
    Neurobiol Aging; 2017 Jan; 49():219.e1-219.e3. PubMed ID: 27814995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel mutation of CHCHD2 p.R8H in a sporadic case of Parkinson's disease.
    Ikeda A; Matsushima T; Daida K; Nakajima S; Conedera S; Li Y; Yoshino H; Oyama G; Funayama M; Nishioka K; Hattori N
    Parkinsonism Relat Disord; 2017 Jan; 34():66-68. PubMed ID: 28341223
    [No Abstract]   [Full Text] [Related]  

  • 32. Genetic analysis of FGF20 variants in Chinese Han patients with essential tremor.
    Yuan L; Song Z; Deng X; Zheng W; Yang Z; Yang Y; Deng H
    Neurosci Lett; 2016 May; 620():159-62. PubMed ID: 27040428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in CHCHD2 cause α-synuclein aggregation.
    Ikeda A; Nishioka K; Meng H; Takanashi M; Hasegawa I; Inoshita T; Shiba-Fukushima K; Li Y; Yoshino H; Mori A; Okuzumi A; Yamaguchi A; Nonaka R; Izawa N; Ishikawa KI; Saiki H; Morita M; Hasegawa M; Hasegawa K; Elahi M; Funayama M; Okano H; Akamatsu W; Imai Y; Hattori N
    Hum Mol Genet; 2019 Dec; 28(23):3895-3911. PubMed ID: 31600778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of variant rs3794087 in SLC1A2 and Parkinson's disease in a Chinese Han population: A case-control study and meta-analysis.
    Cheng Y; Mao CY; Liu YT; Li F; Yang J; Liu H; Zhang C; Wang YL; Wu J; Shi CH; Xu YM
    Neurosci Lett; 2018 Feb; 666():165-168. PubMed ID: 29275184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CHCHD2 and CHCHD10-related neurodegeneration: molecular pathogenesis and the path to precision therapy.
    Shammas MK; Huang TH; Narendra DP
    Biochem Soc Trans; 2023 Apr; 51(2):797-809. PubMed ID: 37021679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rare variant analysis of essential tremor-associated genes in early-onset Parkinson's disease.
    Liang D; Zhao Y; Pan H; Zhou X; He R; Zhou X; Yang J; Wang Y; Zhou X; Zhou Z; Xu Q; Yan X; Li J; Guo J; Tang B; Sun Q
    Ann Clin Transl Neurol; 2021 Jan; 8(1):119-125. PubMed ID: 33185019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic Analysis of LRRK1 and LRRK2 Variants in Essential Tremor Patients.
    Chen H; Yuan L; Song Z; Deng X; Yang Z; Gong L; Zi X; Deng H
    Genet Test Mol Biomarkers; 2018 Jun; 22(6):398-402. PubMed ID: 29812962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders.
    Ogaki K; Koga S; Heckman MG; Fiesel FC; Ando M; Labbé C; Lorenzo-Betancor O; Moussaud-Lamodière EL; Soto-Ortolaza AI; Walton RL; Strongosky AJ; Uitti RJ; McCarthy A; Lynch T; Siuda J; Opala G; Rudzinska M; Krygowska-Wajs A; Barcikowska M; Czyzewski K; Puschmann A; Nishioka K; Funayama M; Hattori N; Parisi JE; Petersen RC; Graff-Radford NR; Boeve BF; Springer W; Wszolek ZK; Dickson DW; Ross OA
    Neurology; 2015 Dec; 85(23):2016-25. PubMed ID: 26561290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of casein kinase 1 epsilon/delta (Csnk1e/d) in the pathogenesis of familial Parkinson's disease caused by CHCHD2.
    Torii S; Arakawa S; Sato S; Ishikawa KI; Taniguchi D; Sakurai HT; Honda S; Hiraoka Y; Ono M; Akamatsu W; Hattori N; Shimizu S
    EMBO Mol Med; 2023 Sep; 15(9):e17451. PubMed ID: 37578019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson's disease.
    Liu X; Wang Q; Yang Y; Stewart T; Shi M; Soltys D; Liu G; Thorland E; Cilento EM; Hou Y; Liu Z; Feng T; Zhang J
    Acta Neuropathol Commun; 2021 Mar; 9(1):37. PubMed ID: 33685516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.